相似文献
1
Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program.
Clin Infect Dis. 2017 Nov 29;65(12):2126-2129. doi: 10.1093/cid/cix613.
2
Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm.
BMC Infect Dis. 2020 Jan 20;20(1):61. doi: 10.1186/s12879-020-4798-1.
3
A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda.
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):231-238. doi: 10.1097/QAI.0000000000001669.
4
Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
BMC Infect Dis. 2020 Feb 14;20(1):141. doi: 10.1186/s12879-020-4862-x.
5
Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
PLoS One. 2019 Jan 10;14(1):e0210105. doi: 10.1371/journal.pone.0210105. eCollection 2019.
6
High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
Clin Infect Dis. 2018 Feb 10;66(5):686-692. doi: 10.1093/cid/cix872.
7
Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
J Acquir Immune Defic Syndr. 2021 Aug 15;87(5):1205-1213. doi: 10.1097/QAI.0000000000002717.
8
Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
HIV Med. 2015 Sep;16(8):468-76. doi: 10.1111/hiv.12245. Epub 2015 Feb 17.
9
Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.
Clin Infect Dis. 2020 Apr 10;70(8):1683-1690. doi: 10.1093/cid/ciz485.
10
Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania.
J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):205-213. doi: 10.1097/QAI.0000000000001899.
引用本文的文献
1
Management and outcome of intracranial fungal infections in children and adults in Africa: a scoping review.
BMC Infect Dis. 2024 Aug 6;24(1):789. doi: 10.1186/s12879-024-09694-2.
2
Baseline C-reactive Protein as a Risk Factor for Cryptococcal Meningitis and Death in HIV-associated Cryptococcal Antigenemia With CrAg Titer as an Effect Modifier.
Open Forum Infect Dis. 2024 Jul 8;11(8):ofae392. doi: 10.1093/ofid/ofae392. eCollection 2024 Aug.
3
Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With HIV-Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen Titers.
Clin Infect Dis. 2025 Feb 5;80(1):129-136. doi: 10.1093/cid/ciae266.
4
Diagnosis and management of cryptococcal meningitis in HIV-infected adults.
Clin Microbiol Rev. 2023 Dec 20;36(4):e0015622. doi: 10.1128/cmr.00156-22. Epub 2023 Nov 28.
5
An evaluation of Mp1p antigen screening for talaromycosis in HIV-infected antiretroviral therapy-naïve population in Guangdong, China.
PLoS Negl Trop Dis. 2023 Nov 27;17(11):e0011785. doi: 10.1371/journal.pntd.0011785. eCollection 2023 Nov.
6
Cryptococcal meningitis.
Nat Rev Dis Primers. 2023 Nov 9;9(1):62. doi: 10.1038/s41572-023-00472-z.
7
Neuromeningeal Cryptococcosis and Tuberculosis Coinfection in Bamako: A One-Year Case Series.
Open Forum Infect Dis. 2023 Aug 18;10(8):ofad438. doi: 10.1093/ofid/ofad438. eCollection 2023 Aug.
8
Disseminated Cryptococcosis Is a Common Finding among Human Immunodeficiency Virus-Infected Patients with Suspected Sepsis and Is Associated with Higher Mortality Rates.
J Fungi (Basel). 2023 Aug 9;9(8):836. doi: 10.3390/jof9080836.
9
Digital Platform for Automatic Qualitative and Quantitative Reading of a Cryptococcal Antigen Point-of-Care Assay Leveraging Smartphones and Artificial Intelligence.
J Fungi (Basel). 2023 Feb 7;9(2):217. doi: 10.3390/jof9020217.
10
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.
PLoS One. 2023 Feb 13;18(2):e0281580. doi: 10.1371/journal.pone.0281580. eCollection 2023.
本文引用的文献
1
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
Lancet Infect Dis. 2017 Aug;17(8):873-881. doi: 10.1016/S1473-3099(17)30243-8. Epub 2017 May 5.
2
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.
Clin Infect Dis. 2016 Mar 1;62(5):581-587. doi: 10.1093/cid/civ936. Epub 2015 Nov 12.
3
Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.
Open Forum Infect Dis. 2015 Apr 2;2(2):ofv046. doi: 10.1093/ofid/ofv046. eCollection 2015 Apr.
4
Lumbar puncture refusal in sub-Saharan Africa: A call for further understanding and intervention.
Neurology. 2015 May 12;84(19):1988-90. doi: 10.1212/WNL.0000000000001561.
5
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
Lancet. 2015 May 30;385(9983):2173-82. doi: 10.1016/S0140-6736(15)60164-7. Epub 2015 Mar 10.
6
The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.
Clin Infect Dis. 2014 Dec 1;59(11):1607-14. doi: 10.1093/cid/ciu596. Epub 2014 Jul 23.
7
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
Clin Infect Dis. 2014 Mar;58(5):736-45. doi: 10.1093/cid/cit794. Epub 2013 Dec 6.
8
Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.
PLoS One. 2013 Oct 4;8(10):e75585. doi: 10.1371/journal.pone.0075585. eCollection 2013.
9
Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.
PLoS One. 2013 Jul 19;8(7):e69288. doi: 10.1371/journal.pone.0069288. Print 2013.
10
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
PLoS Med. 2012;9(9):e1001316. doi: 10.1371/journal.pmed.1001316. Epub 2012 Sep 25.
Zotero 插件